Does anyone know anything about Steve Sjuggerud’s Melt Up Portfolio?
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I heard this presentation the other day, with Steve Sjuggerud and Matt McColl, https://orders.stansberryresearch.com/?cid=MKT496109&eid=MKT497522&plcid=PLC083372&assetId=AST156522&page=1
or if you prefer the transcript instead: https://orders.stansberryresearch.com/?cid=MKT496109&eid=MKT497522&plcid=PLC083372&assetId=AST156523&page=2
They are talking about 9 investments in this “Melt Up Portfolio”, which they’ll reveal to you for a small fee of $2500.
According to them, the Biotech sector is going to be the big one. Apparently, you need to be invested in stocks right now and ride the Melt Up, and they will reveal when to get out as well.
I would love to know what their investments are but $2500 is way out of my league.
Their bonus tip was Beam therapeutics [BEAM].
Anyone else has any thoughts on this?
I just watched it being advertised for $49.00 up to $199. after the time clock runs out. The bonus was ACAD acadia pharm.
It’s a bit late to pass this on, but Sjuggerud has always been the one to get me my biggest gains, and as of today’s close BEAM is up 121% from when I bought it the morning after that reco.
And today, 2/19/21/ BEAM is up 205%! Even at that, it’s 11.5% below its high since that reco!
Could be that BEAM is something. Or maybe not. It has lost 69c, 69c, and $1.69 per share for the last three reporting periods. Not sure why one would conclude this was a particularly great business. Care should be exercised when a following the size of Sjuggerud or Stansberry decide they’re going to ‘get behind’ a trade. Self fulfilling prophecies can be produced as a result giving an advantage to the first to enter and a problem for the last. What to buy, why, and when to sell are interesting aspects of any trading system. Good luck with this one. I am neither long or short the ticker, but noticed that the ad is still running as the stock has falled from $120 to $75…